Ranked: The best-selling pharmaceutical products worldwide, 2024

In 2023, Merck’s cancer drug Keytruda surpassed the COVID-19 vaccine Comirnaty to become the top-selling pharmaceutical product worldwide, generating around $25 billion in revenue. Comirnaty came in second place, with total revenues of $15.3 billion, followed closely by Humira, which generated $14.4 billion in revenue.

Humira is primarily used to treat rheumatoid and psoriatic arthritis, but it is also used to treat a range of other medical conditions, including Crohn’s disease, ankylosing spondylitis, ulcerative colitis, psoriasis, uveitis, and some other autoimmune diseases. The drug is administered through subcutaneous injections and was first approved by the FDA in 2002.

Best-selling pharmaceutical products worldwide

Have you read?
These American Company Slogans (and Taglines) Everyone Knows.
America’s Best Investment Advisory Firms, 2023.
Report: These Are The Most Eaten Foods in the World, 2023.
Most expensive cars in the world, 2023.
These Are the Richest Cities in the World, 2023.
Richest Professional Football Clubs In The World, 2023.

This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.

Email Address*

Name